{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:44:29Z","timestamp":1788281069106,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ajog.2015.03.019","type":"journal-article","created":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T04:00:20Z","timestamp":1426046420000},"page":"141-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013"],"prefix":"10.1016","volume":"213","author":[{"given":"Ahmed M.","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella Xiaoyan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha S.","family":"Kelkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Winkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2015.03.019_bib1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0029-7844(97)00534-6","article-title":"Variation in the incidence of uterine leiomyoma among premenopausal women by age and race","volume":"90","author":"Marshall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0301-2115(02)00308-1","article-title":"Benign gynecological tumors: estimated incidence: results of the German Cohort Study on Women\u2019s Health","volume":"107","author":"Heinemann","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2015.03.019_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib4","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1093\/humrep\/deh407","article-title":"Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study","volume":"19","author":"Marino","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2015.03.019_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/AOG.0b013e318183fbab","article-title":"Alternatives to hysterectomy in the management of leiomyomas. ACOG practice bulletin","volume":"112","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/IJWH.S15710","article-title":"Current and emerging treatments for uterine myoma: an update","volume":"3","author":"Duhan","year":"2011","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.ajog.2015.03.019_bib7","first-page":"200","article-title":"Myomectomy: recurrence after removal of solitary and multiple myomas","volume":"34","author":"Malone","year":"1969","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.fertnstert.2006.07.1497","article-title":"Efficacy of combined laparoscopic uterine artery occlusion and myomectomy via minilaparotomy in the treatment of recurrent uterine myomas","volume":"87","author":"Liu","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2015.03.019_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejogrb.2008.10.006","article-title":"Hysteroscopic myomectomy for menorrhagia using Versascope bipolar system: efficacy and prognostic factors at a minimum of one year follow up","volume":"142","author":"Varma","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2015.03.019_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejogrb.2014.05.029","article-title":"Long-term risk of fibroid recurrence after laparoscopic myomectomy","volume":"180","author":"Radosa","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2015.03.019_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ajog.2006.02.020","article-title":"Health care resource use for uterine fibroid tumors in the United States","volume":"195","author":"Flynn","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib12","first-page":"44","article-title":"Inpatient uterine fibroid costs and complications: National trends and impacts on health care costs","volume":"35","author":"Becker","year":"2008","journal-title":"J\u00a0Health Care Finance"},{"key":"10.1016\/j.ajog.2015.03.019_bib13","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib14","series-title":"Cost-of-illness studies: a primer","first-page":"1","author":"Segel","year":"2006"},{"key":"10.1016\/j.ajog.2015.03.019_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/job.630","article-title":"Presenteeism in the workplace: a\u00a0reviewand research agenda","volume":"31","author":"Johns","year":"2010","journal-title":"J\u00a0Organ Behav"},{"key":"10.1016\/j.ajog.2015.03.019_bib16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1089\/jwh.2005.14.692","article-title":"The economic impact of uterine fibroids in the United States: a summary of published estimates","volume":"14","author":"Mauskopf","year":"2005","journal-title":"J\u00a0Womens Health"},{"key":"10.1016\/j.ajog.2015.03.019_bib17","unstructured":"US BLS. Consumer Price Index- All Urban Consumers - U.S. Medical Care, 1982-84. 2013. Available at: http:\/\/data.bls.gov\/cgi-bin\/surveymost?cu Accessed Aug. 6,\u00a02014."},{"key":"10.1016\/j.ajog.2015.03.019_bib18","first-page":"1","article-title":"National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures","volume":"33","author":"Becker","year":"2007","journal-title":"J\u00a0Health Care Finance"},{"key":"10.1016\/j.ajog.2015.03.019_bib19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/JOM.0b013e3181895e10","article-title":"Impaired work performance among women with symptomatic uterine fibroids","volume":"50","author":"Lerner","year":"2008","journal-title":"J\u00a0Occup Environ Med"},{"key":"10.1016\/j.ajog.2015.03.019_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/JOM.0b013e31805f6cf2","article-title":"The direct and indirect cost burden of clinically significant and symptomatic uterine fibroids","volume":"49","author":"Lee","year":"2007","journal-title":"J\u00a0Occup Environ Med"},{"key":"10.1016\/j.ajog.2015.03.019_bib21","first-page":"405","article-title":"Lifetime costs of patients with clinically detected uterine fibroids: an employer\u2019s perspective","volume":"18","author":"Wu","year":"2006","journal-title":"Drug Benefit Trends"},{"key":"10.1016\/j.ajog.2015.03.019_bib22","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.AOG.0000234651.41000.58","article-title":"Annual costs associated with diagnosis of uterine leiomyomata","volume":"108","author":"Hartmann","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib23","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jvir.2008.03.001","article-title":"Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial","volume":"19","author":"Volkers","year":"2008","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.ajog.2015.03.019_bib24","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1067\/mob.2002.127374","article-title":"Cost analysis of myomectomy, hysterectomy, and uterine artery embolization","volume":"187","author":"Al-Fozan","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jamasurg.2013.131","article-title":"Impact of minimally invasive surgery on medical spending and employee absenteeism","volume":"148","author":"Epstein","year":"2013","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ajog.2015.03.019_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jmig.2008.09.581","article-title":"Rate, type, and cost of invasive interventions for uterine myomas in Germany, France, and England","volume":"16","author":"Fernandez","year":"2009","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib27","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jmig.2007.06.008","article-title":"Robot-assisted laparoscopic myomectomy versus abdominal myomectomy: a comparison of short-term surgical outcomes and immediate costs","volume":"14","author":"Advincula","year":"2007","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib28","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jvir.2007.07.007","article-title":"Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids","volume":"18","author":"Dembek","year":"2007","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.ajog.2015.03.019_bib29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00270-005-0369-5","article-title":"Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization","volume":"30","author":"Goldberg","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ajog.2015.03.019_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jmig.2005.11.008","article-title":"Randomized study of laparoscopic versus minilaparotomic myomectomy for uterine myomas","volume":"13","author":"Alessandri","year":"2006","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib31","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1067\/mob.2002.127596","article-title":"Abdominal or vaginal hysterectomy for enlarged uteri: a randomized clinical trial","volume":"187","author":"Benassi","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib32","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S1051-0443(07)61966-6","article-title":"Estimated costs for uterine artery embolization and abdominal myomectomy for uterine leiomyomata: a comparative study at a single institution","volume":"13","author":"Baker","year":"2002","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.ajog.2015.03.019_bib33","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/jwh.2008.0456","article-title":"What are the total costs of surgical treatment for uterine fibroids?","volume":"17","author":"Carls","year":"2008","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2015.03.019_bib34","first-page":"3481","article-title":"Evaluating the feasibility and safety of vaginal myomectomy in China","volume":"124","author":"Yu","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ajog.2015.03.019_bib35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1051-0443(07)61477-8","article-title":"Uterine artery embolization for leiomyomata: resource use and cost estimation","volume":"12","author":"Subramanian","year":"2001","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.ajog.2015.03.019_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00404-007-0332-6","article-title":"Characterization of therapy and costs for patients with uterine fibroids in Utah Medicaid","volume":"276","author":"Oderda","year":"2007","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2015.03.019_bib37","first-page":"583","article-title":"Outcome and resource use associated with myomectomy","volume":"98","author":"Subramanian","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib38","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S1076-6332(03)80563-9","article-title":"Hospital costs of uterine artery embolization and hysterectomy for uterine fibroid tumors","volume":"9","author":"Beinfeld","year":"2002","journal-title":"Acad Radiol"},{"key":"10.1016\/j.ajog.2015.03.019_bib39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00404-011-1999-2","article-title":"Robotic-assisted laparoscopic myomectomy versus abdominal myomectomy: a comparative analysis of surgical outcomes and costs","volume":"285","author":"Nash","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2015.03.019_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2050-5736-2-7","article-title":"Cost comparison between uterine-sparing fibroid treatments one year following treatment","volume":"2","author":"Borah","year":"2014","journal-title":"J\u00a0Ther Ultrasound"},{"key":"10.1016\/j.ajog.2015.03.019_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1028-4559(09)60273-4","article-title":"Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas","volume":"48","author":"Wang","year":"2009","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.03.019_bib42","unstructured":"Food and Drug Administration. Quantitative assessment of the prevalence of unsuspected uterine sarcoma in women undergoing treatment of uterine fibroids. Available at: http:\/\/www.fda.gov\/downloads\/MedicalDevices\/Safety\/AlertsandNotices\/UCM393589.pdf. Accessed April 17,\u00a02014."},{"key":"10.1016\/j.ajog.2015.03.019_bib43","series-title":"Identification of future research needs in the comparative management of uterine fibroid disease. a report on the priority-setting process, preliminary data analysis, and research plan","author":"Gliklich","year":"2011"},{"key":"10.1016\/j.ajog.2015.03.019_bib44","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/jwh.2013.4334","article-title":"The burden of uterine fibroids for African-American women: results of a national survey","volume":"22","author":"Stewart","year":"2013","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2015.03.019_bib45","unstructured":"PCORI. PCORI, AHRQ Announce Research Team Selected to Compare Treatments for Uterine Fibroids. 2014. Available at: http:\/\/www.pcori.org\/content\/pcori-ahrq-announce-research-team-selected-compare-treatments-uterine-fibroids. Accessed Feb. 6,\u00a02015."},{"key":"10.1016\/j.ajog.2015.03.019_bib46","series-title":"Biometry: the principles and practice of statistics in biological research, 4th ed","author":"Sokal","year":"2012"},{"key":"10.1016\/j.ajog.2015.03.019_bib47","unstructured":"Jenkinson C. Assessment and evaluation of\u00a0health and medical care: a methods text. Buckingham, UK: Open University Press, 1997."},{"key":"10.1016\/j.ajog.2015.03.019_bib48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/jwh.2011.3147","article-title":"Cost burden and treatment patterns associated with management of heavy menstrual bleeding","volume":"21","author":"Jensen","year":"2012","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2015.03.019_bib49","first-page":"402","article-title":"Heavy menstrual bleeding treatment patterns and associated health care utilization and costs","volume":"19","author":"Copher","year":"2012","journal-title":"J\u00a0Clin Outcomes Manag"},{"key":"10.1016\/j.ajog.2015.03.019_bib50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.fertnstert.2009.02.069","article-title":"Uterine artery embolization for fibroids is associated with an increased risk of miscarriage","volume":"94","author":"Homer","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2015.03.019_bib51","first-page":"34","article-title":"Complementary medicine treatment of uterine fibroids: a pilot study","volume":"8","author":"Mehl-Madrona","year":"2002","journal-title":"Altern\u00a0Ther Health Med"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815002355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815002355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T17:10:11Z","timestamp":1715447411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937815002355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0002937815002355"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2015.03.019","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2015.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}